CoChat
Sign Up
Cited by 402

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Biological interactions of carbon-based nanomaterials: From coronation to degradation

Bhattacharya, Kunal, Mukherjee, Sourav P., Gallud, Audrey, Burkert, Seth C., Bistarelli, Silvia, Bellucci, Stefano, Bottini, Massimo, Star, Alexander, Fadeel, Bengt·2016·Nanomedicine: Nanotechnology, Biology and Medicine
DOI 10.1016/j.nano.2015.11.011PMC PMC4789123
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nano.2015.11.011

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 166

  1. Fadeel, 2013, Nanosafety: towards safer design of nanomedicines, J Intern Med, 274, 578, 10.1111/joim.12137 · DOI
  2. Langer, 2015, Nanotechnology, JAMA, 313, 135, 10.1001/jama.2014.16315 · DOI
  3. Mundra, 2014, Nanotubes in biological applications, Curr Opin Biotechnol, 28, 25, 10.1016/j.copbio.2013.10.012 · DOI
  4. Chen, 2015, Theranostic applications of carbon nanomaterials in cancer: focus on imaging and cargo delivery, J Control Release, 210, 230, 10.1016/j.jconrel.2015.04.021 · DOI
  5. Tonelli, 2015, Graphene-based nanomaterials: biological and medical applications and toxicity, Nanomedicine (Lond), 10, 2423, 10.2217/nnm.15.65 · DOI
  6. Farrera, 2014, Extracellular entrapment and degradation of single-walled carbon nanotubes, Nanoscale, 6, 6974, 10.1039/c3nr06047k · DOI
  7. Kunzmann, 1810, Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation, Biochim Biophys Acta, 2011, 361
  8. Monopoli, 2012, Biomolecular coronas provide the biological identity of nanosized materials, Nat Nanotechnol, 7, 779, 10.1038/nnano.2012.207 · DOI · Paper page
  9. Farrera, 2015, It takes two to tango: understanding the interactions between engineered nanomaterials and the immune system, Eur J Pharm Biopharm, 95, 3, 10.1016/j.ejpb.2015.03.007 · DOI · Paper page
  10. Kroto, 1985, C60: Buckminsterfullerene, Nature, 318, 162, 10.1038/318162a0 · DOI
  11. Iijima, 1991, Helical microtubules of graphitic carbon, Nature, 354, 56, 10.1038/354056a0 · DOI
  12. Monthioux, 2006, Who should be given credit for the discovery of carbon nanotubes?, Carbon, 44, 1621, 10.1016/j.carbon.2006.03.019 · DOI
  13. Novoselov, 2004, Electric field effect in atomically thin carbon films, Science, 306, 666, 10.1126/science.1102896 · DOI · Paper page
  14. Ferrari, 2015, Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems, Nanoscale, 7, 4598, 10.1039/C4NR01600A · DOI
  15. Mochalin, 2011, The properties and applications of nanodiamonds, Nat Nanotechnol, 7, 11, 10.1038/nnano.2011.209 · DOI
  16. Park, 2013, Facing the truth about nanotechnology in drug delivery, ACS Nano, 7, 7442, 10.1021/nn404501g · DOI
  17. Ding, 2015, Graphene-based materials in regenerative medicine, Adv Healthc Mater, 4, 1451, 10.1002/adhm.201500203 · DOI
  18. Kane, 2008, Nanotoxicology: the asbestos analogy revisited, Nat Nanotechnol, 3, 378, 10.1038/nnano.2008.182 · DOI
  19. Shvedova, 2012, Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress, Toxicol Appl Pharmacol, 261, 121, 10.1016/j.taap.2012.03.023 · DOI
  20. Bhattacharya, 2013, Mechanisms of carbon nanotube-induced toxicity: focus on pulmonary inflammation, Adv Drug Deliv Rev, 65, 2087, 10.1016/j.addr.2013.05.012 · DOI
  21. Grosse, 2014, International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes, Lancet Oncol, 15, 1427, 10.1016/S1470-2045(14)71109-X · DOI
  22. Sanchez, 2012, Biological interactions of graphene-family nanomaterials: an interdisciplinary review, Chem Res Toxicol, 25, 15, 10.1021/tx200339h · DOI
  23. Bussy, 2013, Safety considerations for graphene: lessons learnt from carbon nanotubes, Acc Chem Res, 46, 692, 10.1021/ar300199e · DOI
  24. Godwin, 2015, Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making, ACS Nano, 9, 3409, 10.1021/acsnano.5b00941 · DOI
  25. Pescatori, 2013, Functionalized carbon nanotubes as immunomodulator systems, Biomaterials, 34, 4395, 10.1016/j.biomaterials.2013.02.052 · DOI
  26. Meunier, 2012, Double-walled carbon nanotubes trigger IL-1β release in human monocytes through Nlrp3 inflammasome activation, Nanomedicine, 8, 987, 10.1016/j.nano.2011.11.004 · DOI
  27. Palomäki, 2011, Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism, ACS Nano, 5, 6861, 10.1021/nn200595c · DOI
  28. Yang, 2013, Functionalization of carbon nanoparticles modulates inflammatory cell recruitment and NLRP3 inflammasome activation, Small, 9, 4194, 10.1002/smll.201300481 · DOI
  29. Boraschi, 2012, Interaction of nanoparticles with immunocompetent cells: nanosafety considerations, Nanomedicine (Lond), 7, 121, 10.2217/nnm.11.169 · DOI
  30. Sydlik, 2015, In vivo compatibility of graphene oxide with differing oxidation states, ACS Nano, 9, 3866, 10.1021/acsnano.5b01290 · DOI
  31. Tkach, 2011, Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure, ACS Nano, 5, 5755, 10.1021/nn2014479 · DOI
  32. Tkach, 2013, Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells, Small, 9, 1686, 10.1002/smll.201201546 · DOI
  33. Shurin, 2014, Graphene oxide attenuates Th2-type immune responses, but augments airway remodeling and hyperresponsiveness in a murine model of asthma, ACS Nano, 8, 5585, 10.1021/nn406454u · DOI
  34. Bhirde, 2009, Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery, ACS Nano, 3, 307, 10.1021/nn800551s · DOI
  35. Kam, 2005, Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction, Proc Natl Acad Sci U S A, 102, 11600, 10.1073/pnas.0502680102 · DOI
  36. Kostarelos, 2007, Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type, Nat Nanotechnol, 2, 108, 10.1038/nnano.2006.209 · DOI
  37. Al-Jamal, 2011, Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing, Proc Natl Acad Sci U S A, 108, 10952, 10.1073/pnas.1100930108 · DOI
  38. Sacchetti, 2014, Polyethylene-glycol-modified single-walled carbon nanotubes for intra-articular delivery to chondrocytes, ACS Nano, 8, 12280, 10.1021/nn504537b · DOI
  39. Novoselov, 2012, A roadmap for graphene, Nature, 490, 192, 10.1038/nature11458 · DOI
  40. Yang, 2010, Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy, Nano Lett, 10, 3318, 10.1021/nl100996u · DOI
  41. Yang, 2012, Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles, Adv Mater, 24, 1868, 10.1002/adma.201104964 · DOI
  42. Ma, 2012, A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging, Nano Res, 5, 199, 10.1007/s12274-012-0200-y · DOI
  43. Qin, 2014, Theranostic GO-based nanohybrid for tumor induced imaging and potential combinational tumor therapy, Small, 10, 599, 10.1002/smll.201301613 · DOI
  44. Dellinger, 2013, Application of fullerenes in nanomedicine: an update, Nanomedicine (Lond), 8, 1191, 10.2217/nnm.13.99 · DOI
  45. Maeda-Mamiya, 2010, In vivo gene delivery by cationic tetraamino fullerene, Proc Natl Acad Sci U S A, 107, 5339, 10.1073/pnas.0909223107 · DOI
  46. Lu, 2012, Current status and future developments of endohedral metallofullerenes, Chem Soc Rev, 41, 7723, 10.1039/c2cs35214a · DOI
  47. Kang, 2012, Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine, Proc Natl Acad Sci U S A, 109, 15431, 10.1073/pnas.1204600109 · DOI
  48. Balogh, 2015, Caging cancer, Nanomedicine, 11, 867, 10.1016/j.nano.2015.02.005 · DOI
  49. Pan, 2015, Gd-metallofullerenol nanomaterial suppresses pancreatic cancer metastasis by inhibiting the interaction of histone deacetylase 1 and metastasis-associated protein 1, ACS Nano, 9, 6826, 10.1021/nn506782f · DOI
  50. Liu, 2015, Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor, Nat Commun, 6, 5988, 10.1038/ncomms6988 · DOI
  51. Gallud, 2015, Keeping it small: towards a molecular definition of nanotoxicology, Eur J Nanomedicine, 7, 143, 10.1515/ejnm-2015-0020 · DOI
  52. Fletcher, 2010, ABC transporters in cancer: more than just drug efflux pumps, Nat Rev Cancer, 10, 147, 10.1038/nrc2789 · DOI
  53. Prados, 2012, Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy, Anticancer Agents Med Chem, 12, 1058, 10.2174/187152012803529646 · DOI
  54. Farokhzad, 2009, Impact of nanotechnology on drug delivery, ACS Nano, 3, 16, 10.1021/nn900002m · DOI
  55. Chow, 2011, Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment, Sci Transl Med, 3, 10.1126/scitranslmed.3001713 · DOI
  56. Wang, 2014, Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells, ACS Nano, 8, 12151, 10.1021/nn503491e · DOI
  57. Yoo, 2015, Graphene-based nanomaterials for versatile imaging studies, Chem Soc Rev, 44, 4835, 10.1039/C5CS00072F · DOI
  58. De la Zerda, 2008, Carbon nanotubes as photoacoustic molecular imaging agents in living mice, Nat Nanotechnol, 3, 557, 10.1038/nnano.2008.231 · DOI
  59. Ghosh, 2014, Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes, Proc Natl Acad Sci U S A, 111, 13948, 10.1073/pnas.1400821111 · DOI
  60. Delogu, 2012, Functionalized multiwalled carbon nanotubes as ultrasound contrast agents, Proc Natl Acad Sci U S A, 109, 16612, 10.1073/pnas.1208312109 · DOI
  61. Shi, 2013, Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy, Biomaterials, 34, 4786, 10.1016/j.biomaterials.2013.03.023 · DOI
  62. Ge, 2014, A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation, Nat Commun, 5, 4596, 10.1038/ncomms5596 · DOI
  63. Shi, 2014, A fullerene-based multi-functional nanoplatform for cancer theranostic applications, Biomaterials, 35, 5771, 10.1016/j.biomaterials.2014.03.071 · DOI
  64. Fu, 2007, Characterization and application of single fluorescent nanodiamonds as cellular biomarkers, Proc Natl Acad Sci U S A, 104, 727, 10.1073/pnas.0605409104 · DOI
  65. Wang, 2015, Carbon nanomaterial-based electrochemical biosensors: an overview, Nanoscale, 7, 6420, 10.1039/C5NR00585J · DOI
  66. Iverson, 2013, In vivo biosensing via tissue-localizable near-infrared-fluorescent single-walled carbon nanotubes, Nat Nanotechnol, 8, 873, 10.1038/nnano.2013.222 · DOI
  67. Liu, 2010, Biocompatible graphene oxide-based glucose biosensors, Langmuir, 26, 6158, 10.1021/la100886x · DOI
  68. Jiang, 2013, Real-time electrical detection of nitric oxide in biological systems with sub-nanomolar sensitivity, Nat Commun, 4, 2225, 10.1038/ncomms3225 · DOI
  69. Ku, 2013, Carbon-based nanomaterials for tissue engineering, Adv Healthc Mater, 2, 244, 10.1002/adhm.201200307 · DOI
  70. Cellot, 2009, Carbon nanotubes might improve neuronal performance by favouring electrical shortcuts, Nat Nanotechnol, 4, 126, 10.1038/nnano.2008.374 · DOI
  71. Bosi, 2015, From 2D to 3D: novel nanostructured scaffolds to investigate signalling in reconstructed neuronal networks, Sci Rep, 5, 9562, 10.1038/srep09562 · DOI
  72. Thalhammer, 2010, The use of nanodiamond monolayer coatings to promote the formation of functional neuronal networks, Biomaterials, 31, 2097, 10.1016/j.biomaterials.2009.11.109 · DOI
  73. Solanki, 2013, Axonal alignment and enhanced neuronal differentiation of neural stem cells on graphene-nanoparticle hybrid structures, Adv Mater, 25, 5477, 10.1002/adma.201302219 · DOI
  74. Docter, 2015, The nanoparticle biomolecule corona: lessons learned—challenge accepted?, Chem Soc Rev, 44, 6094, 10.1039/C5CS00217F · DOI
  75. Fadeel, 2013, Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials, Wiley Interdiscip Rev Nanomed Nanobiotechnol, 5, 111, 10.1002/wnan.1206 · DOI
  76. Bhattacharya, 2014, Shifting identities of metal oxide nanoparticles: focus on inflammation, MRS Bull, 39, 970, 10.1557/mrs.2014.220 · DOI
  77. Salvati, 2013, Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface, Nat Nanotechnol, 8, 137, 10.1038/nnano.2012.237 · DOI · Paper page
  78. Kelly, 2015, Mapping protein binding sites on the biomolecular corona of nanoparticles, Nat Nanotechnol, 10, 472, 10.1038/nnano.2015.47 · DOI · Paper page
  79. Hamad-Schifferli, 2015, Exploiting the novel properties of protein coronas: emerging applications in nanomedicine, Nanomedicine (Lond), 10, 1663, 10.2217/nnm.15.6 · DOI
  80. Dutta, 2007, Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials, Toxicol Sci, 100, 303, 10.1093/toxsci/kfm217 · DOI
  81. Ge, 2011, Binding of blood proteins to carbon nanotubes reduces cytotoxicity, Proc Natl Acad Sci U S A, 108, 16968, 10.1073/pnas.1105270108 · DOI
  82. Gao, 2011, Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFκB activation and reduces its immunotoxicity, ACS Nano, 5, 4581, 10.1021/nn200283g · DOI
  83. Hu, 2011, Protein corona-mediated mitigation of cytotoxicity of graphene oxide, ACS Nano, 5, 3693, 10.1021/nn200021j · DOI
  84. Chong, 2015, Reduced cytotoxicity of graphene nanosheets mediated by blood-protein coating, ACS Nano, 9, 5713, 10.1021/nn5066606 · DOI
  85. Duan, 2015, Protein corona mitigates the cytotoxicity of graphene oxide by reducing its physical interaction with cell membrane, Nanoscale, 7, 15214, 10.1039/C5NR01839K · DOI
  86. Gu, 2015, The role of basic residues in the adsorption of blood proteins onto the graphene surface, Sci Rep, 5, 10873, 10.1038/srep10873 · DOI
  87. Gu, 2015, Surface curvature relation to protein adsorption for carbon-based nanomaterials, Sci Rep, 5, 10886, 10.1038/srep10886 · DOI
  88. Kapralov, 2012, Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration, ACS Nano, 6, 4147, 10.1021/nn300626q · DOI
  89. Gasser, 2010, The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry, J Nanobiotechnol, 8, 31, 10.1186/1477-3155-8-31 · DOI
  90. Huang, 2015, Inhibiting the VIM-2 metallo-β-lactamase by graphene oxide and carbon nanotubes, ACS Appl Mater Interfaces, 7, 9898, 10.1021/acsami.5b01954 · DOI
  91. De, 2011, Graphene oxide as an enzyme inhibitor: modulation of activity of α-chymotrypsin, J Am Chem Soc, 133, 17524, 10.1021/ja208427j · DOI
  92. Li, 2013, Simple colorimetric bacterial detection and high-throughput drug screening based on a graphene-enzyme complex, Nanoscale, 5, 619, 10.1039/C2NR32704J · DOI
  93. Jin, 2012, Functionalized graphene oxide in enzyme engineering: a selective modulator for enzyme activity and thermostability, ACS Nano, 6, 4864, 10.1021/nn300217z · DOI
  94. Moghimi, 2014, Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth, J Control Release, 190, 556, 10.1016/j.jconrel.2014.03.051 · DOI
  95. Salvador-Morales, 2006, Complement activation and protein adsorption by carbon nanotubes, Mol Immunol, 43, 193, 10.1016/j.molimm.2005.02.006 · DOI
  96. Hamad, 2008, Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover, Mol Immunol, 45, 3797, 10.1016/j.molimm.2008.05.020 · DOI
  97. Tan, 2013, Functionalization of graphene oxide generates a unique interface for selective serum protein interactions, ACS Appl Mater Interfaces, 5, 1370, 10.1021/am302706g · DOI
  98. Moghimi, 2015, Insidious pathogen-mimicking properties of nanoparticles in triggering the lectin pathway of the complement system, Eur J Nanomedicine, 7, 263, 10.1515/ejnm-2015-0014 · DOI
  99. Bottini, 2011, PEG-modified carbon nanotubes in biomedicine: current status and challenges ahead, Biomacromolecules, 12, 3381, 10.1021/bm201020h · DOI
  100. Pombo García, 2014, Zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system, Small, 10, 2516, 10.1002/smll.201303540 · DOI
  101. Yameen, 2014, Insight into nanoparticle cellular uptake and intracellular targeting, J Control Release, 190, 485, 10.1016/j.jconrel.2014.06.038 · DOI
  102. Krais, 2014, Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum, Nanomedicine, 10, 1421, 10.1016/j.nano.2014.01.006 · DOI
  103. Dai, 2014, Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting, Angew Chem Int Ed Engl, 53, 5093, 10.1002/anie.201309464 · DOI
  104. Dai, 2015, Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas, ACS Nano, 9, 2876, 10.1021/nn506929e · DOI
  105. Hadjidemetriou, 2015, In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles, ACS Nano, 9, 8142, 10.1021/acsnano.5b03300 · DOI · Paper page
  106. Sacchetti, 2013, In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes, Bioconjug Chem, 24, 852, 10.1021/bc400070q · DOI
  107. Hong, 2012, In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene, ACS Nano, 6, 2361, 10.1021/nn204625e · DOI
  108. Hajipour, 2015, Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide, Nanoscale, 7, 8978, 10.1039/C5NR00520E · DOI
  109. Moghimi, 2012, Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective, Annu Rev Pharmacol Toxicol, 52, 481, 10.1146/annurev-pharmtox-010611-134623 · DOI
  110. Phillips, 2010, Targeted nanodelivery of drugs and diagnostics, Nano Today, 5, 143, 10.1016/j.nantod.2010.03.003 · DOI
  111. Tasciotti, 2008, Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications, Nat Nanotechnol, 3, 151, 10.1038/nnano.2008.34 · DOI
  112. Ali-Boucetta, 2013, Pharmacology of carbon nanotubes: toxicokinetics, excretion and tissue accumulation, Adv Drug Deliv Rev, 65, 2111, 10.1016/j.addr.2013.10.004 · DOI
  113. Singh, 2006, Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers, Proc Natl Acad Sci U S A, 103, 3357, 10.1073/pnas.0509009103 · DOI
  114. Ruggiero, 2010, Paradoxical glomerular filtration of carbon nanotubes, Proc Natl Acad Sci U S A, 107, 12369, 10.1073/pnas.0913667107 · DOI · Paper page
  115. Al-Jamal, 2012, Degree of chemical functionalization of carbon nanotubes determines tissue distribution and excretion profile, Angew Chem Int Ed Engl, 51, 6389, 10.1002/anie.201201991 · DOI
  116. Wang, 2014, The relationship between the diameter of chemically-functionalized multi-walled carbon nanotubes and their organ biodistribution profiles in vivo, Biomaterials, 35, 9517, 10.1016/j.biomaterials.2014.07.054 · DOI
  117. Yang, 2011, In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice, ACS Nano, 5, 516, 10.1021/nn1024303 · DOI
  118. Jasim, 2015, Tissue distribution and urinary excretion of intravenously administered chemically functionalized graphene oxide sheets, Chem Sci, 6, 3952, 10.1039/C5SC00114E · DOI
  119. Wick, 2014, Classification framework for graphene-based materials, Angew Chem Int Ed Engl, 53, 7714, 10.1002/anie.201403335 · DOI
  120. Cherukuri, 2006, Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence, Proc Natl Acad Sci U S A, 103, 18882, 10.1073/pnas.0609265103 · DOI
  121. Yang, 2007, Biodistribution of pristine single-walled carbon nanotubes in vivo, J Phys Chem C, 111, 17761, 10.1021/jp070712c · DOI
  122. Chen, 2015, Mass spectrometry imaging reveals the sub-organ distribution of carbon nanomaterials, Nat Nanotechnol, 10, 176, 10.1038/nnano.2014.282 · DOI
  123. Huang, 2013, Effect of injection routes on the biodistribution, clearance, and tumor uptake of carbon dots, ACS Nano, 7, 5684, 10.1021/nn401911k · DOI
  124. Vachet, 2015, Molecular histology: more than a picture, Nat Nanotechnol, 10, 103, 10.1038/nnano.2015.4 · DOI
  125. Girish, 2013, Confocal Raman imaging study showing macrophage mediated biodegradation of graphene in vivo, Adv Healthc Mater, 2, 1489, 10.1002/adhm.201200489 · DOI
  126. Liu, 2007, In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice, Nat Nanotechnol, 2, 47, 10.1038/nnano.2006.170 · DOI
  127. Sacchetti, 2013, Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance, ACS Nano, 7, 1974, 10.1021/nn400409h · DOI
  128. Yuan, 2012, Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor, Adv Mater, 24, 5476, 10.1002/adma.201202296 · DOI
  129. Smith, 2014, Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery, Nat Nanotechnol, 9, 481, 10.1038/nnano.2014.62 · DOI
  130. Mantovani, 2015, The interaction of anticancer therapies with tumor-associated macrophages, J Exp Med, 212, 435, 10.1084/jem.20150295 · DOI
  131. Kotchey, 2013, Peroxidase-mediated biodegradation of carbon nanotubes in vitro and in vivo, Adv Drug Deliv Rev, 65, 1921, 10.1016/j.addr.2013.07.007 · DOI
  132. Ye, 2013, Coal as an abundant source of graphene quantum dots, Nat Commun, 4, 2943, 10.1038/ncomms3943 · DOI
  133. Dong, 2015, Natural carbon-based dots from humic substances, Sci Rep, 5, 10037, 10.1038/srep10037 · DOI
  134. Su, 2011, New insight into the soot nanoparticles in a candle flame, Chem Commun, 47, 4700, 10.1039/c0cc05785a · DOI
  135. Li, 2008, Processable aqueous dispersions of graphene nanosheets, Nat Nanotechnol, 3, 101, 10.1038/nnano.2007.451 · DOI
  136. Liu, 2008, Graphene oxidation: thickness-dependent etching and strong chemical doping, Nano Lett, 8, 1965, 10.1021/nl0808684 · DOI
  137. Allen, 2008, Biodegradation of single-walled carbon nanotubes through enzymatic catalysis, Nano Lett, 8, 3899, 10.1021/nl802315h · DOI
  138. Allen, 2009, Mechanistic investigations of horseradish peroxidase-catalyzed degradation of single-walled carbon nanotubes, J Am Chem Soc, 131, 17194, 10.1021/ja9083623 · DOI
  139. Zhao, 2011, Enzymatic degradation of multiwalled carbon nanotubes, J Phys Chem A, 115, 9536, 10.1021/jp112324d · DOI · Paper page
  140. Russier, 2011, Oxidative biodegradation of single- and multi-walled carbon nanotubes, Nanoscale, 3, 10.1039/C0NR00779J · DOI
  141. Flores-Cervantes, 2014, Slow biotransformation of carbon nanotubes by horseradish peroxidase, Environ Sci Technol, 48, 4826, 10.1021/es4053279 · DOI
  142. Kotchey, 2011, The enzymatic oxidation of graphene oxide, ACS Nano, 5, 2098, 10.1021/nn103265h · DOI
  143. Schreiner, 2009, White-rot basidiomycete-mediated decomposition of C60 fullerol, Environ Sci Technol, 43, 3162, 10.1021/es801873q · DOI
  144. Berry, 2014, Oxidative enzymatic response of white-rot fungi to single-walled carbon nanotubes, Environ Pollut, 193, 197, 10.1016/j.envpol.2014.06.013 · DOI
  145. Lalwani, 2014, Enzymatic degradation of oxidized and reduced graphene nanoribbons by lignin peroxidase, J Mater Chem B Mater Biol Med, 2, 6354, 10.1039/C4TB00976B · DOI · Paper page
  146. Zhang, 2013, Degradation of multiwall carbon nanotubes by bacteria, Environ Pollut, 181, 335, 10.1016/j.envpol.2013.05.058 · DOI
  147. Liu, 2015, Oxidation and degradation of graphitic materials by naphthalene-degrading bacteria, Nanoscale, 7, 13619, 10.1039/C5NR02502H · DOI
  148. Kagan, 2010, Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation, Nat Nanotechnol, 5, 354, 10.1038/nnano.2010.44 · DOI
  149. Andón, 2013, Biodegradation of single-walled carbon nanotubes by eosinophil peroxidase, Small, 9, 2721, 10.1002/smll.201202508 · DOI
  150. Bhattacharya, 2015, Lactoperoxidase-mediated degradation of single-walled carbon nanotubes in the presence of pulmonary surfactant, Carbon, 91, 506, 10.1016/j.carbon.2015.05.022 · DOI
  151. Bai, 2014, Insight into the mechanism of graphene oxide degradation via the photo-fenton reaction, J Phys Chem C, 118, 10519, 10.1021/jp503413s · DOI
  152. Pan, 2013, Assessing DNA damage from enzyme-oxidized single-walled carbon nanotubes, Toxicol Res, 2, 375, 10.1039/c3tx50022e · DOI
  153. Lu, 2014, Binding of human serum albumin to single-walled carbon nanotubes activated neutrophils to increase production of hypochlorous acid, the oxidant capable of degrading nanotubes, Chem Res Toxicol, 27, 1070, 10.1021/tx5001317 · DOI
  154. Shvedova, 2012, Impaired clearance and enhanced pulmonary inflammatory/fibrotic response to carbon nanotubes in myeloperoxidase-deficient mice, PLoS One, 7, e30923, 10.1371/journal.pone.0030923 · DOI
  155. Kagan, 2014, Lung macrophages "digest" carbon nantubes using a superoxide/peroxynitrite oxidative pathway, ACS Nano, 8, 5610, 10.1021/nn406484b · DOI
  156. Zhang, 2015, Biodegradation of carbon nanohorns in macrophage cells, Nanoscale, 7, 2834, 10.1039/C4NR06175F · DOI
  157. Elgrabli, 2015, Carbon nanotube degradation in macrophages: live nanoscale monitoring and understanding of biological pathway, ACS Nano, 9, 10113, 10.1021/acsnano.5b03708 · DOI
  158. Nunes, 2012, In vivo degradation of functionalized carbon nanotubes after stereotactic administration in the brain cortex, Nanomedicine (Lond), 7, 1485, 10.2217/nnm.12.33 · DOI
  159. Bhattacharya, 2014, Enzymatic 'stripping' and degradation of PEGylated carbon nanotubes, Nanoscale, 6, 14686, 10.1039/C4NR03604B · DOI
  160. Yang, 2009, Biodefunctionalization of functionalized single-walled carbon nanotubes in mice, Biomacromolecules, 10, 2009, 10.1021/bm900263z · DOI
  161. Allen, 2008, Synthesis, characterization, and manipulation of nitrogen-doped carbon nanotube cups, ACS Nano, 2, 1914, 10.1021/nn800355v · DOI
  162. Zhao, 2015, Nano-gold corking and enzymatic uncorking of carbon nanotube cups, J Am Chem Soc, 137, 675, 10.1021/ja511843w · DOI
  163. Seo, 2015, Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications, Nanoscale, 7, 8689, 10.1039/C5NR00251F · DOI
  164. Kurapati, 2015, Dispersibility-dependent biodegradation of graphene oxide by myeloperoxidase, Small, 11, 3985, 10.1002/smll.201500038 · DOI
  165. Li, 2014, Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene, Small, 10, 1544, 10.1002/smll.201303234 · DOI
  166. Fadel, 2014, Immunotherapy applications of carbon nanotubes: from design to safe applications, Trends Biotechnol, 32, 198, 10.1016/j.tibtech.2014.02.005 · DOI

Cited by

Sorted by citations

See all 402

Metadata

Authors
Bhattacharya, K., Mukherjee, S. P., Gallud, A., Burkert, S. C., Bistarelli, S., Bellucci, S., Bottini, M., Star, A., & Fadeel, B.
Venue
Nanomedicine: Nanotechnology, Biology and Medicine
Publisher
Elsevier BV
Published
2016-02
Volume
12
Issue
2
Pages
333-351
ISSN
1549-9634
DOI
10.1016/j.nano.2015.11.011
PMC
PMC4789123
Cited by
402
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biological interactions of carbon-based nanomaterials: From coronation to degradation. https://app.cochat.ai/papers/10.1016/j.nano.2015.11.011
The paper
Bhattacharya, K., Mukherjee, S. P., Gallud, A., Burkert, S. C., Bistarelli, S., Bellucci, S., Bottini, M., Star, A., & Fadeel, B. (2016). Biological interactions of carbon-based nanomaterials: From coronation to degradation. Nanomedicine: Nanotechnology, Biology and Medicine. https://doi.org/10.1016/j.nano.2015.11.011